Amine Raji

Co-founder & CEO, Spore.Bio

📍 France🔄 Updated September 2026💼 5 investments📅 1 years investing🗓 Last invested May 2026
VC🌍 FranceInvested this year
5
Total investments
2
Early stage
0
Mid stage
1
Late stage
1y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
May 2026
Davis is an AI-native real estate company accelerating early-stage development and architectural design
Angel Investor
Mar 2026
AI infrastructure turning surgical video into documentation, coding, and clinical-grade workflows
Angel Investor
Feb 2025
ZeroEntropy is developing a world class retrieval system that continuously improves over time for developers building AI products.
Angel Investor
Jan 2025
Nous sommes Jay&Joy, la 1ère crèmerie végétale de France. Notre ambition : préserver le vivant en plaçant le végétal au centre de notre alimentation 🌱 Nous fabriquons des alternatives au fromage à base de lait damande et de noix de cajou. Notre gamme est certifiée bio et vegan 💛 Chaque produit est préparé et affiné de façon artisanale dans notre atelier près de Compiègne, dans lOise 🇫🇷
Angel Investor
Jan 2025
Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
Experience · 7 entries
All (7)
Investments (5)
Founder (2)
2026
Angel Investor
May 2026
Davis is an AI-native real estate company accelerating early-stage development and architectural design
Angel Investor
Mar 2026
AI infrastructure turning surgical video into documentation, coding, and clinical-grade workflows
2025
Angel Investor
Feb 2025
ZeroEntropy is developing a world class retrieval system that continuously improves over time for developers building AI products.
Angel Investor
Jan 2025
Nous sommes Jay&Joy, la 1ère crèmerie végétale de France. Notre ambition : préserver le vivant en plaçant le végétal au centre de notre alimentation 🌱 Nous fabriquons des alternatives au fromage à base de lait damande et de noix de cajou. Notre gamme est certifiée bio et vegan 💛 Chaque produit est préparé et affiné de façon artisanale dans notre atelier près de Compiègne, dans lOise 🇫🇷
Angel Investor
Jan 2025
Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
Show all 7 entries ↓
Investment activity
2025–2026 · 5 investments
2025320262
Recent (last 2 years)Earlier